BACKGROUND & AIMS: Alagille syndrome is an autosomal dominant disorder caused by mutations in Notch signaling pathway genes, usually JAGGED1. Up to 40% of Alagille syndrome patients also display exocrine pancreatic insufficiency, the pathobiology of which is unknown. Additionally, no mouse model recapitulating this aspect of the disease has been reported. METHODS: We conditionally deleted both alleles of Jagged1 in the murine pancreas using Cre-loxP technology and analyzed histologic and morphologic features in postnatal and adult pancreas such as duct structure, acinar mass, and T-lymphocyte infiltration, as well as markers of pancreatic function, including fecal fat. RESULTS: Jagged1-deficient mice displayed malformed pancreatic ducts with resulting acinar cell death, fatty infiltration of the parenchyma, fibrosis, pancreatitis, and pancreatic insufficiency. CONCLUSIONS: Pancreatic ductal malformation and acinar cell loss may be responsible for pancreatic insufficiency in Jagged1-deficient mice and, by corollary, in Alagille syndrome patients.
BACKGROUND & AIMS:Alagille syndrome is an autosomal dominant disorder caused by mutations in Notch signaling pathway genes, usually JAGGED1. Up to 40% of Alagille syndromepatients also display exocrine pancreatic insufficiency, the pathobiology of which is unknown. Additionally, no mouse model recapitulating this aspect of the disease has been reported. METHODS: We conditionally deleted both alleles of Jagged1 in the murine pancreas using Cre-loxP technology and analyzed histologic and morphologic features in postnatal and adult pancreas such as duct structure, acinar mass, and T-lymphocyte infiltration, as well as markers of pancreatic function, including fecal fat. RESULTS:Jagged1-deficient mice displayed malformed pancreatic ducts with resulting acinar cell death, fatty infiltration of the parenchyma, fibrosis, pancreatitis, and pancreatic insufficiency. CONCLUSIONS:Pancreatic ductal malformation and acinar cell loss may be responsible for pancreatic insufficiency in Jagged1-deficient mice and, by corollary, in Alagille syndromepatients.
Authors: Daniel Kopinke; Marisa Brailsford; Fong Cheng Pan; Mark A Magnuson; Christopher V E Wright; L Charles Murtaugh Journal: Dev Biol Date: 2011-11-29 Impact factor: 3.582
Authors: Daniel Kopinke; Marisa Brailsford; Jill E Shea; Rebecca Leavitt; Courtney L Scaife; L Charles Murtaugh Journal: Development Date: 2011-02 Impact factor: 6.868
Authors: Pierre-Paul Prévot; Alexandru Simion; Adrien Grimont; Marta Colletti; Abed Khalaileh; Géraldine Van den Steen; Christine Sempoux; Xiaobo Xu; Véronique Roelants; Jacob Hald; Luc Bertrand; Harry Heimberg; Stephen F Konieczny; Yuval Dor; Frédéric P Lemaigre; Patrick Jacquemin Journal: Gut Date: 2012-01-22 Impact factor: 23.059
Authors: Maria L Golson; John Le Lay; Nan Gao; Nuria Brämswig; Kathleen M Loomes; Rebecca Oakey; Catherine L May; Peter White; Klaus H Kaestner Journal: Mech Dev Date: 2009-06-06 Impact factor: 1.882
Authors: Maria L Golson; Matthew F Maulis; Jennifer C Dunn; Greg Poffenberger; Jonathan Schug; Klaus H Kaestner; Maureen A Gannon Journal: Mol Endocrinol Date: 2014-07-29